CLINICAL TRIALS PROFILE FOR AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
✉ Email this page to a colleague
All Clinical Trials for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02292069 ↗ | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fed Condition | Completed | Dr. Reddy's Laboratories Limited | Phase 1 | 2011-09-01 | This study is to assess the bioequivalence between Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg of Dr. Reddy's Laboratories Limited, India and CADUET® (amlodipine besylate and atorvastatin calcium) tablets 10mg/80mg of Pfizer Ireland Pharmaceuticals Dublin, Ireland in healthy, adult,human subjects under Fed conditions. |
NCT02295046 ↗ | Bioavailability Study of Amlodipine Besylate/Atorvastatin Calcium Tablets 10/80 mg Under Fasting Condition | Completed | Dr. Reddy's Laboratories Limited | Phase 1 | 2011-10-01 | This study is to assess the bioequivalence between Amlodipine besylate/Atorvastatin calcium Tablets 10mg/80mg of Dr. Reddy's Laboratories Limited, India and CADUET® (amlodipine besylate and atorvastatin calcium) tablets 10mg/80mg of Pfizer Ireland Pharmaceuticals Dublin, Ireland in Healthy Male and Female Volunteers under Fasting conditions. |
NCT03299452 ↗ | Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor | Unknown status | Alphacait, LLC | Phase 2 | 2017-01-01 | This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor. |
NCT03299452 ↗ | Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor | Unknown status | Haining Health-Coming Biotech Co., Ltd. | Phase 2 | 2017-01-01 | This is a single-center, open-label, single-arm, non-randomized study designed to evaluate PFS, safety, overall survival (OS), objective response rate (OPR), disease control rate (DCR) and biomarkers of cancer therapy based on Alphacait screening system in subjects with advanced malignant tumor. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Condition Name
Clinical Trial Locations for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Clinical Trial Progress for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Clinical Trial Phase
Clinical Trial Sponsors for AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM
Sponsor Name